A prospective patient registry to monitor safety, effectiveness, and utilisation of bedaquiline in patients with multidrug-resistant tuberculosis in South Korea

Abstract Background Multidrug-resistant tuberculosis (MDR-TB) represents a major public health concern, with an ongoing need for new effective treatments. Bedaquiline is an oral diarylquinoline that has shown encouraging treatment success and culture conversion rates in MDR-TB. Methods A South Korea...

Description complète

Détails bibliographiques

Auteurs principaux:	Tae Sun Shim, Helen Pai, JeongHa Mok, Seung Heon Lee, Yong-Soo Kwon, Jae Chol Choi, JaeSeok Park, Eileen Birmingham, Gary Mao, Lori Alquier, Kourtney Davis, Florence Thoret-Bauchet, Ji Hyun Kim, Hyeongyeong Kim, Nyasha Bakare
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2023-01-01
Collection:	BMC Infectious Diseases
Sujets:	Tuberculosis Multidrug-resistant Bedaquiline South Korea
Accès en ligne:	https://doi.org/10.1186/s12879-022-07955-6
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!